Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Nav1.7, also known as sodium channel protein type 7 subunit alpha, is a voltage-gated sodium channel primarily expressed in peripheral neurons, especially at the endings of pain-sensing nerves called nociceptors. It is encoded by the SCN9A gene and plays a critical role in generating and conducting action potentials in excitable cells, particularly sensory neurons involved in pain perception. Mutations in SCN9A can cause severe pain syndromes or congenital insensitivity to pain, making Nav1.7 a target for analgesic drug development.
Blockade of sodium ion conductance through the Nav1.7 channel pore.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Sodium Channel Protein Type 7 Subunit Alpha (Nav1.7).